160 related articles for article (PubMed ID: 4214223)
1. Factors in human serum promoting phagocytosis of Pseudomonas aeruginosa. I. Interaction of opsonins with the bacterium.
Bjornson AB; Michael JG
J Infect Dis; 1974 Nov; 130 Suppl(0):S119-26. PubMed ID: 4214223
[No Abstract] [Full Text] [Related]
2. Human immunity to Pseudomonas aeruginosa. II. Relationship between heat-stable opsonins and type-specific lipopolysaccharides.
Young LS
J Infect Dis; 1972 Sep; 126(3):277-87. PubMed ID: 4626510
[No Abstract] [Full Text] [Related]
3. Factors in human serum promoting phagocytosis of Pseudomonas aeruginosa. II. Interaction of opsonins with the phagocytic cell.
Bjornson AB; Michael JG
J Infect Dis; 1974 Nov; 130 Suppl(0):S127-31. PubMed ID: 4214224
[No Abstract] [Full Text] [Related]
4. Role of antibody in infections due to Pseudomonas aeruginosa.
Young LS
J Infect Dis; 1974 Nov; 130 Suppl(0):S111-8. PubMed ID: 4213568
[No Abstract] [Full Text] [Related]
5. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. II. Opsonic, agglutinative, and protective capacities of immunoglobulin G anti-Pseudomonas antibodies.
Bjornson AB; Michael JG
Infect Immun; 1972 May; 5(5):775-82. PubMed ID: 4629252
[TBL] [Abstract][Full Text] [Related]
6. Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.
Young LS; Armstrong D
J Infect Dis; 1972 Sep; 126(3):257-76. PubMed ID: 4626509
[No Abstract] [Full Text] [Related]
7. Characterization of the human immune response to a polysaccharide vaccine from Pseudomonas aeruginosa.
Pier GB; Thomas DM
J Infect Dis; 1983 Aug; 148(2):206-13. PubMed ID: 6411830
[TBL] [Abstract][Full Text] [Related]
8. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. I. Interaction between immunoglobulins, heat-labile serum factors, and phagocytic cells in the killing of bacteria.
Bjornson AB; Michael JG
Infect Immun; 1971 Oct; 4(4):462-7. PubMed ID: 5005303
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa.
Penketh AR; Pitt TL; Hodson ME; Batten JC
J Med Microbiol; 1983 Nov; 16(4):401-8. PubMed ID: 6417338
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay.
Fick RB; Naegel GP; Matthay RA; Reynolds HY
J Clin Invest; 1981 Oct; 68(4):899-914. PubMed ID: 6793632
[TBL] [Abstract][Full Text] [Related]
11. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
Peterson PK; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie PG
J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
[TBL] [Abstract][Full Text] [Related]
12. Participation of nonspecific factors in the destruction of type M 12 streptococcus in vitro. I. Nonspecific absorption of anti-M 12 bactericidal activity.
Kahlich R; Procházka O
J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):75-87. PubMed ID: 4985648
[No Abstract] [Full Text] [Related]
13. Protective mechanism of the immune response to a ribosomal vaccine from Pseudomonas aeruginosa. II. In vitro bactericidal and opsonophagocytic studies with specific antiserum.
Lieberman MM; Frank WJ; Brady AV
J Surg Res; 1988 Mar; 44(3):251-8. PubMed ID: 3125389
[TBL] [Abstract][Full Text] [Related]
14. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins.
Pier GB; Grout M; Desjardins D
J Immunol; 1991 Sep; 147(6):1869-76. PubMed ID: 1832427
[TBL] [Abstract][Full Text] [Related]
15. Different serum requirements for opsonization of two serologically identical strains of Pseudomonas aeruginosa.
Ogle CK; Ogle JD; Stinnett JD; Stace P; Alexander JW
Immunol Commun; 1980; 9(7):677-91. PubMed ID: 6160089
[TBL] [Abstract][Full Text] [Related]
16. Human plasma fibronectin effect on serum-mediated uptake of Pseudomonas aeruginosa PA 1348A by human granulocytes.
Boulanger MJ; Smith RP; Baltch AL; Blumenstock FA; Saba TM
Complement; 1985; 2(4):230-4. PubMed ID: 3938371
[TBL] [Abstract][Full Text] [Related]
17. Bacterial blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection.
Guttman RM; Waisbren BA
Clin Exp Immunol; 1975 Jan; 19(1):121-30. PubMed ID: 54231
[TBL] [Abstract][Full Text] [Related]
18. The antibacterial efficiencies of ovine IgA, IgM, and IgG.
Knop JG; Rowley D
J Infect Dis; 1974 Oct; 130(4):368-73. PubMed ID: 4216609
[No Abstract] [Full Text] [Related]
19. Use of monoclonal antibodies to protein F of Pseudomonas aeruginosa as opsonins for phagocytosis by macrophages.
Battershill JL; Speert DP; Hancock RE
Infect Immun; 1987 Oct; 55(10):2531-3. PubMed ID: 3115901
[TBL] [Abstract][Full Text] [Related]
20. Anti-Pseudomonas heat-stable opsonins in acute lymphoblastic leukemia of childhood.
Wollman MR; Young LS; Armstrong D; Haghbin M
J Pediatr; 1975 Mar; 86(3):376-81. PubMed ID: 803559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
